Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Bruna R, Benedetti F, Boccomini C, Patti C, Barbui AM, Pulsoni A, Musso M, Liberati AM, Gini G, Castellino C, Rossini F, Ciceri F, Rota-Scalabrini D, Stelitano C, Di Raimondo F, Tucci A, Devizzi L, Zoli V, Zallio F, Narni F, Dondi A, Parvis G, Semenzato G, Lanza F, Perrone T, Angrilli F, Billio A, Gueli A, Mantoan B, Rambaldi A, Gianni AM, Corradini P, Passera R, Ladetto M, Tarella C.

Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2.

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib.

Mian M, Pescosta N, Badiali S, Cappelletto PC, Marcheselli L, Luminari S, Patriarca F, Zambello R, Pascarella A, Tagariello G, Marabese A, Mondello P, Billio A, Cortelazzo S.

Br J Haematol. 2019 Jun;185(5):944-947. doi: 10.1111/bjh.15645. Epub 2018 Nov 26. No abstract available.

PMID:
30478966
3.

A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.

Olivieri J, Mosna F, Pelosini M, Fama A, Rattotti S, Giannoccaro M, Carli G, Tisi MC, Ferrero S, Sgherza N, Mazzone AM, Marino D, Calimeri T, Loseto G, Saraceni F, Tomei G, Sica S, Perali G, Codeluppi K, Billio A, Olivieri A, Orciuolo E, Matera R, Stefani PM, Borghero C, Ghione P, Cascavilla N, Lanza F, Chiusolo P, Finotto S, Federici I, Gherlinzoni F, Centurioni R, Fanin R, Zaja F; Fondazione Italiana Linfomi Postgraduate Master Course.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1814-1822. doi: 10.1016/j.bbmt.2018.05.018. Epub 2018 May 29.

4.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.

Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L, Perez AM, Coscia M, Laurenti L, Musuraca G, Farina L, Delgado AR, Orlandi EM, Galieni P, Mauro FR, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, Eyre TA, Kennedy B, Bowles KM, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P; GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum.

Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.

5.

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.

Gallamini A, Tarella C, Viviani S, Rossi A, Patti C, Mulé A, Picardi M, Romano A, Cantonetti M, La Nasa G, Trentin L, Bolis S, Rapezzi D, Battistini R, Gottardi D, Gavarotti P, Corradini P, Cimminiello M, Schiavotto C, Parvis G, Zanotti R, Gini G, Ferreri AJM, Viero P, Miglino M, Billio A, Avigdor A, Biggi A, Fallanca F, Ficola U, Gregianin M, Chiaravalloti A, Prosperini G, Bergesio F, Chauvie S, Pavoni C, Gianni AM, Rambaldi A.

J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.

PMID:
29360414
6.

Impressive tissue regeneration of severe oral mucositis post stem cell transplantation using cord blood platelet gel.

Piccin A, Rebulla P, Pupella S, Tagnin M, Marano G, Di Pierro AM, Santodirocco M, Di Mauro L, Beqiri L, Kob M, Primerano M, Casini M, Billio A, Eisendle K, Fontanella F.

Transfusion. 2017 Sep;57(9):2220-2224. doi: 10.1111/trf.14205. Epub 2017 Jun 27.

PMID:
28656652
7.

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.

Cortelazzo S, Tarella C, Gianni AM, Ladetto M, Barbui AM, Rossi A, Gritti G, Corradini P, Di Nicola M, Patti C, Mulé A, Zanni M, Zoli V, Billio A, Piccin A, Negri G, Castellino C, Di Raimondo F, Ferreri AJ, Benedetti F, La Nasa G, Gini G, Trentin L, Frezzato M, Flenghi L, Falorio S, Chilosi M, Bruna R, Tabanelli V, Pileri S, Masciulli A, Delaini F, Boschini C, Rambaldi A.

J Clin Oncol. 2016 Nov 20;34(33):4015-4022. doi: 10.1200/JCO.2016.67.2980. Epub 2016 Oct 31.

8.

Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.

Moling O, Piccin A, Tauber M, Marinello P, Canova M, Casini M, Negri G, Raffeiner B, Binazzi R, Gandini L, Vecchiato C, Rimenti G, Billio A.

J Med Case Rep. 2016 Sep 15;10(1):254. doi: 10.1186/s13256-016-0993-5.

9.

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program.

Zinzani PL, Pellegrini C, Cerciello G, Monaco F, Volpetti S, Peli A, Angelucci E, Corradini P, Cox MC, Guarini A, Musso M, Bresciani P, Amato G, Billio A, Caparrotti G, Figuera A, Nassi L, Gaudio F, Grossi A, Onida F, Merli M, Rigacci L, Argnani L.

Leuk Lymphoma. 2016 Oct;57(10):2370-4. doi: 10.3109/10428194.2015.1137292. Epub 2016 Feb 17.

PMID:
26732313
10.

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma.

Mian M, Marcheselli L, Rossi A, Visco C, Chiappella A, Volpetti S, Zaja F, Mondello P, Fiegl M, Billio A, Federico M, Luminari S, Rambaldi A, Cortelazzo S.

Ann Oncol. 2014 Dec;25(12):2398-404. doi: 10.1093/annonc/mdu462. Epub 2014 Oct 1.

PMID:
25274614
11.

Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma).

Tarella C, Arcaini L, Baldini L, Barosi G, Billio A, Marchetti M, Rambaldi A, Vitolo U, Zinzani PL, Tura S.

Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):75-85. doi: 10.1016/j.clml.2014.07.002. Epub 2014 Jul 15. Review.

PMID:
25108679
12.

Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group.

Cuneo A, Marchetti M, Barosi G, Billio A, Brugiatelli M, Ciolli S, Laurenti L, Mauro FR, Molica S, Montillo M, Zinzani P, Tura S.

Leuk Res. 2014 Nov;38(11):1269-77. doi: 10.1016/j.leukres.2014.06.017. Epub 2014 Jul 7.

PMID:
25063524
13.

SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.

Corradini P, Marchetti M, Barosi G, Billio A, Gallamini A, Pileri S, Pimpinelli N, Rossi G, Zinzani PL, Tura S.

Ann Oncol. 2014 Dec;25(12):2339-50. doi: 10.1093/annonc/mdu152. Epub 2014 Apr 9.

14.

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.

Magni M, Di Nicola M, Patti C, Scimè R, Mulè A, Rambaldi A, Intermesoli T, Viero P, Tarella C, Gueli A, Bergui L, Trentin L, Barzan A, Benedetti F, Ambrosetti A, Di Raimondo F, Chiarenza A, Parvis G, Billio A, Attolico I, Olivieri A, Montanari M, Carlo-Stella C, Matteucci P, Devizzi L, Guidetti A, Viviani S, Valagussa P, Gianni AM.

Bone Marrow Transplant. 2014 Apr;49(4):485-91. doi: 10.1038/bmt.2013.214. Epub 2014 Jan 20.

PMID:
24442244
15.

Ovarian hyperstimulation syndrome in systemic amyloidosis.

Piccin A, Vezzali N, Pescosta N, Steurer M, Palladini G, Billio A.

Amyloid. 2014 Mar;21(1):69-70. doi: 10.3109/13506129.2013.868801. Epub 2014 Jan 16.

PMID:
24433119
16.

WITHDRAWN: Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.

Billio A, Morello E, Clarke MJ.

Cochrane Database Syst Rev. 2013 Dec 9;(12):CD006272. doi: 10.1002/14651858.CD006272.pub3. Review. No abstract available.

PMID:
24323437
17.

Idiopathic thrombocytopenic purpura resistant to eltrombopag, but cured with romiplostim.

Piccin A, Amaddii G, Natolino F, Billio A, Cortelazzo S.

Blood Transfus. 2014 Jan;12 Suppl 1:s149-50. doi: 10.2450/2013.0289-12. Epub 2013 Apr 17. No abstract available.

18.

SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.

Zinzani PL, Marchetti M, Billio A, Barosi G, Carella AM, Lazzarino M, Martelli M, Rambaldi A, Rigacci L, Tarella C, Vitolo U, Tura S; Expert Panel of the Italian Society of Hematology.

Am J Hematol. 2013 Mar;88(3):185-92. doi: 10.1002/ajh.23372. Epub 2013 Jan 22.

19.

SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma.

Barosi G, Merlini G, Billio A, Boccadoro M, Corradini P, Marchetti M, Massaia M, Tosi P, Palumbo A, Cavo M, Tura S.

Ann Hematol. 2012 Jun;91(6):875-88. doi: 10.1007/s00277-012-1445-y. Epub 2012 Apr 4. Review.

PMID:
22476884
20.

Osteolytic bone lesions as a rare sign of progression of chronic lymphocytic leukemia without evidence of Richter syndrome.

Mian M, Cerú S, Billio A, Rosanelli C, Cortelazzo S.

Leuk Lymphoma. 2012 May;53(5):993-5. doi: 10.3109/10428194.2011.634044. Epub 2011 Dec 7. No abstract available.

PMID:
22023522
21.

SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia.

Mauro FR, Bandini G, Barosi G, Billio A, Brugiatelli M, Cuneo A, Lauria F, Liso V, Marchetti M, Meloni G, Montillo M, Zinzani P, Tura S; Italian Society of Hematology; Società Italiana di Ematologia Sperimentale; Gruppo Italiano Trapianto di Midollo Osseo.

Leuk Res. 2012 Apr;36(4):459-66. doi: 10.1016/j.leukres.2011.08.013. Epub 2011 Sep 1.

PMID:
21885123
22.

Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy.

Giampaolo A, Abbonizio F, Puopolo M, Arcieri R, Mannucci PM; Italian Association of Haemophilia Centres, Hassan HJ, Accorsi A, Ettorre PC, Schiavoni M, Palareti G, Rodorigo G, Valdré L, Amaddii G, Billio A, Notarangelo L, Iannacaro P, Muleo P, Biasioli C, Rossi V, Alatri A, Testa S, Vincenzi D, Scapoli G, Morfini M, Molinari AC, Lapecorella M, Mariani G, Baudo F, Caimi MT, Federici AB, Gringeri A, Mannucci PM, Santagostino E, Marietta M, Coppola A, Di Minno G, Perricone C, Schiavulli M, Miraglia E, Rocino A, Zanon E, Gagliano F, Mancuso G, Siragusa S, Rivolta F, Tagliaferri A, Gamba G, Iorio A, Oliovecchio E, Dragani A, Arbasi MC, Albertini P, Mancino A, Lombardo VT, Latella C, D'Incà M, Landolfi Raffaele, Biondo Francesca, Mazzucconi MG, Santoro Cristina, Mameli AL, Piseddu G, Schinco PC, Messina M, Rossetti G, Barillari G, Feola G, Franchini M, Gandini G, Castaman G, Rodeghiero F.

Transfus Med. 2011 Aug;21(4):280-4. doi: 10.1111/j.1365-3148.2011.01074.x. Epub 2011 Mar 30. No abstract available.

PMID:
21733006
23.

Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.

Morello E, Pagani L, Coser P, Cavattoni I, Cortelazzo S, Casini M, Billio A, Rossi G.

Bone Marrow Transplant. 2011 Jan;46(1):132-6. doi: 10.1038/bmt.2010.76. Epub 2010 Apr 12.

PMID:
20383205
24.

Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.

Laszlo D, Andreola G, Rigacci L, Fabbri A, Rabascio C, Mancuso P, Pruneri G, Radice D, Pinto A, Frigeri F, Calabrese L, Billio A, Bertolini F, Martinelli G.

J Clin Oncol. 2010 May 1;28(13):2233-8. doi: 10.1200/JCO.2009.23.6315. Epub 2010 Apr 5.

PMID:
20368573
25.

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines.

Santini V, Alessandrino PE, Angelucci E, Barosi G, Billio A, Di Maio M, Finelli C, Locatelli F, Marchetti M, Morra E, Musto P, Visani G, Tura S; Italian Society of Hematology.

Leuk Res. 2010 Dec;34(12):1576-88. doi: 10.1016/j.leukres.2010.01.018. Epub 2010 Feb 11.

PMID:
20149927
26.

Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.

Billio A, Morello E, Clarke MJ.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006272. doi: 10.1002/14651858.CD006272.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;12:CD006272.

PMID:
20091591
27.

Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2'-deoxyadenosine (2-CdA) and Rituximab.

Rabascio C, Laszlo D, Andreola G, Saronni L, Radice D, Rigacci L, Fabbri A, Frigeri F, Calabrese L, Billio A, Bertolini F, Martinelli G.

Leuk Res. 2010 Apr;34(4):454-7. doi: 10.1016/j.leukres.2009.07.002. Epub 2009 Aug 3.

PMID:
19647871
28.

Primary high-grade B-cell lymphoma of the choroid plexus.

Cecchi PC, Billio A, Colombetti V, Rizzo P, Ricci UM, Schwarz A.

Clin Neurol Neurosurg. 2008 Jan;110(1):75-9. Epub 2007 Oct 24.

PMID:
17928135
29.

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

Gallamini A, Zaja F, Patti C, Billio A, Specchia MR, Tucci A, Levis A, Manna A, Secondo V, Rigacci L, Pinto A, Iannitto E, Zoli V, Torchio P, Pileri S, Tarella C.

Blood. 2007 Oct 1;110(7):2316-23. Epub 2007 Jun 20.

30.

A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high-dose cytarabine.

Billio A, Svaldi M, Morello E, Amato B, Coser P.

Am J Hematol. 2006 Oct;81(10):798-9. No abstract available.

31.

Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.

Olivieri A, Santini G, Patti C, Chisesi T, De Souza C, Rubagotti A, Aversa S, Billio A, Porcellini A, Candela M, Centurioni R, Congiu AM, Brunori M, Nati S, Spriano M, Vimercati R, Marino G, Contu A, Tedeschi L, Majolino I, Crugnola M, Sertoli MR; NHLCSG.

Ann Oncol. 2005 Dec;16(12):1941-8. Epub 2005 Sep 12.

PMID:
16157621
32.

A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.

Billio A, Steer EJ, Pianezze G, Svaldi M, Casin M, Amato B, Coser P, Cross NC.

Haematologica. 2002 May;87(5):ECR15. No abstract available.

PMID:
12010678
33.

"Isolated" peritoneal granulocytic sarcoma with molecular and chromosomal bone marrow involvement.

Billio A, Pianezze G, Amato B, Fabris P.

Haematologica. 2002 Jan;87(1):EIM01. No abstract available.

PMID:
11801482
34.

Chronic neutrophilic leukemia evolving from polycythemia vera with multiple chromosome rearrangements: a case report.

Billio A, Venturi R, Morello E, Rosanelli C, Pescosta N, Coser P.

Haematologica. 2001 Nov;86(11):1225-6. No abstract available.

35.

Treatment of Kasabach-Merritt syndrome by embolisation of a giant liver hemangioma.

Billio A, Pescosta N, Rosanelli C, Zanon GF, Gamba PG, Savastano S, Coser P.

Am J Hematol. 2001 Feb;66(2):140-1.

36.

Hermansky-Pudlak syndrome: clinical presentation and confirmation of the value of the mepacrine-based cytofluorimetry test in the diagnosis of delta granule deficiency.

Billio A, Moeseneder C, Donazzan G, Triani A, Pescosta N, Coser P.

Haematologica. 2001 Feb;86(2):220. No abstract available.

37.

Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency.

Peyvandi F, Jenkins PV, Mannucci PM, Billio A, Zeinali S, Perkins SJ, Perry DJ.

Thromb Haemost. 2000 Aug;84(2):250-7.

PMID:
10959697
38.

A brief intensive chemotherapy in T-prolymphocytic leukemia.

Billio A, Pescosta N, Rosanelli C, Fabris P, Coser P.

Haematologica. 2000 Apr;85(4):438-9. No abstract available.

39.

Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP.

Bobbio-Pallavicini E, Gugliotta L, Centurioni R, Porta C, Vianelli N, Billio A, Tacconi F, Ascari E.

Haematologica. 1997 Jul-Aug;82(4):429-35.

40.

Successful short-term oral surgery prophylaxis with rFVIIa in severe congenital factor VII deficiency.

Billio A, Pescosta N, Rosanelli C, Amaddii G, Fontanella F, Coser P.

Blood Coagul Fibrinolysis. 1997 Jun;8(4):249-50. No abstract available.

PMID:
9199823
41.

Thrombotic thrombocytopenic purpura and relapses: why do case series differ? The Italian Cooperative Group for TTP.

Porta C, Centurioni R, Vianelli N, Bobbio-Pallavicini E, Gugliotta L, Billio A.

Am J Hematol. 1996 Jul;52(3):215-6.

42.

Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP.

Centurioni R, Bobbio-Pallavicini E, Porta C, Rodeghiero F, Gugliotta L, Billio A, Tacconi F, Ascari E.

Haematologica. 1995 Jul-Aug;80(4):325-31.

43.

Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura.

Bobbio-Pallavicini E, Porta C, Tacconi F, Gugliotta L, Centurioni R, Vianelli N, Billio A, Ascari E.

Haematologica. 1994 Sep-Oct;79(5):429-37. Review.

44.

Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP.

Bobbio-Pallavicini E, Porta C, Centurioni R, Gugliotta L, Vianelli N, Tacconi F, Billio A, Ascari E.

Eur J Haematol. 1994 Apr;52(4):222-6.

PMID:
8005232

Supplemental Content

Loading ...
Support Center